- Home
- NSTS vs INMB Comparison
NSTS vs INMB Comparison
Compare NSTS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NSTS | INMB |
|---|---|---|
| Founded | 1921 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.6M | 64.7M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NSTS | INMB |
|---|---|---|
| Price | $14.02 | $2.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 8.2K | ★ 339.7K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $252,000.00 | $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $10.73 | $1.09 |
| 52 Week High | $14.05 | $2.50 |
Technical Indicators
Market Signals| Indicator | NSTS | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 73.54 | 58.65 |
| Support Level | $13.70 | $1.16 |
| Resistance Level | $14.04 | $2.50 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 80.95 | 52.51 |
Price Performance
Historical ComparisonAbout NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.